Usefulness of Hexamethylenetetramine in Combination With Chemotherapy Using Free and Pegylated Liposomal Doxorubicin in Vivo, Referring to the Effect on Quiescent Cells

Oncology Reports - Greece
doi 10.3892/or_00000355
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

A Phase II Study of Bortezomib in Combination With Pegylated Liposomal Doxorubicin for Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Clinical Medicine Reviews in Women's Health
2010English

Pegylated Liposomal Doxorubicin in the Treatment of Primary Cutaneous T-Cell Lymphomas

Haematologica
Hematology
2007English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Modeling Pegylated Liposomal Doxorubicin-Induced Hand-Foot Syndrome and Intestinal Mucositis in Zebrafish

OncoTargets and Therapy
OncologyPharmacology
2014English

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)

Scientific Reports
Multidisciplinary
2019English

Safety and Efficacy of Pegylated Liposomal Doxorubicin in HIV-associated Kaposi’s Sarcoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Combination of Chemotherapy and Au-Nanoparticle Photothermy in the Visible Light to Tackle Doxorubicin Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy